Clinical–imaging–pathological correlation in pulmonary hypertension associated with left heart disease
暂无分享,去创建一个
P. Dorfmüller | E. Nossent | A. Vonk Noordegraaf | P. Trip | M. C. van de Veerdonk | Lize Roosma | Deepa Gopalan
[1] M. Götte,et al. The role and implications of left atrial fibrosis in surgical mitral valve repair as assessed by CMR: the ALIVE study design and rationale , 2023, Frontiers in Cardiovascular Medicine.
[2] B. Borlaug,et al. Heart Failure With Preserved Ejection Fraction: JACC Scientific Statement. , 2023, Journal of the American College of Cardiology.
[3] D. Playford,et al. Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes , 2023, Heart.
[4] D. Playford,et al. Prevalence of pulmonary hypertension in aortic stenosis and its influence on outcomes , 2023, Heart.
[5] F. Eisenhaber,et al. Diagnostic accuracy of the electrocardiogram for heart failure with reduced or preserved ejection fraction. , 2023, Journal of cardiac failure.
[6] D. Burkhoff,et al. Left atrial enlargement is associated with pulmonary vascular disease in heart failure with preserved ejection fraction , 2023, European journal of heart failure.
[7] P. Kellman,et al. Cardiovascular magnetic resonance phenotyping of heart failure with mildly reduced ejection fraction , 2022, European heart journal. Cardiovascular Imaging.
[8] N. Brunetti,et al. Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension , 2022, ERJ Open Research.
[9] Jeroen J. Bax,et al. Valvular heart disease: shifting the focus to the myocardium , 2022, European heart journal.
[10] M. Humbert,et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. , 2022, European heart journal.
[11] G. Beck,et al. Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease. , 2022, Journal of the American College of Cardiology.
[12] R. Carter,et al. Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea. , 2022, JAMA cardiology.
[13] Sanjiv J. Shah,et al. Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease , 2022, Circulation research.
[14] A. van Rossum,et al. The Value of Passive Leg Raise During Right Heart Catheterization in Diagnosing Heart Failure With Preserved Ejection Fraction , 2022, Circulation. Heart failure.
[15] Andrew J. Sauer,et al. Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management , 2022, Heart.
[16] J. Marcus,et al. Right Ventricular and Right Atrial Function Are Less Compromised in Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction: A Comparison With Pulmonary Arterial Hypertension With Similar Pressure Overload , 2021, Circulation. Heart failure.
[17] P. Jakuška,et al. The association of left ventricular histologically verified myocardial fibrosis with pulmonary hypertension in severe aortic stenosis , 2021, Perfusion.
[18] B. Prendergast,et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. , 2021, European heart journal.
[19] J. McMurray,et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.
[20] R. Steeds,et al. Reverse Myocardial Remodeling Following Valve Repair in Patients With Chronic Severe Primary Degenerative Mitral Regurgitation. , 2021, JACC. Cardiovascular imaging.
[21] M. Markl,et al. Cine MRI characterizes HFpEF and HFrEF in post-capillary pulmonary hypertension. , 2021, European journal of radiology.
[22] T. Nagai,et al. Presence and relevance of mid-systolic notching on right ventricular outflow tract flow velocity envelopes in pulmonary hypertension due to heart failure. , 2020, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[23] L. Harbaum,et al. Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry. , 2020, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[24] M. Obokata,et al. Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation. , 2020, Journal of the American College of Cardiology.
[25] Mario J. Garcia,et al. State of the Art: Imaging for Myocardial Viability: A Scientific Statement From the American Heart Association. , 2020, Circulation. Cardiovascular imaging.
[26] J. Cavalcante,et al. Impact of Combined Pre and Postcapillary Pulmonary Hypertension on Survival after Transcatheter Aortic Valve Implantation. , 2020, The American journal of cardiology.
[27] F. Rutten,et al. Epidemiology of heart failure , 2020, European journal of heart failure.
[28] S. Solomon,et al. Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failure , 2020, European journal of heart failure.
[29] Brandon C. Benefield,et al. Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension , 2020, ESC heart failure.
[30] G. Simonneau,et al. The revised definition of pulmonary hypertension: exploring the impact on patient management , 2019, European heart journal supplements : journal of the European Society of Cardiology.
[31] P. Lancellotti,et al. Pulmonary Hypertension with Valvular Heart Disease: When to Treat the Valve Disease and When to Treat the Pulmonary Hypertension , 2019, Current Cardiology Reports.
[32] M. Salerno,et al. Myocardial T1 and ECV Measurement: Underlying Concepts and Technical Considerations. , 2019, JACC. Cardiovascular imaging.
[33] J. Barberà,et al. Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[34] Erwan Donal,et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). , 2019, European heart journal.
[35] M. Ghigna,et al. Pulmonary vascular disease and pulmonary hypertension , 2019, Diagnostic Histopathology.
[36] Erwan Donal,et al. Left Atrial Structure and Function, and Left Ventricular Diastolic Dysfunction: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.
[37] D. Celermajer,et al. Pulmonary vasodilator therapies are of no benefit in pulmonary hypertension due to left heart disease: A meta-analysis. , 2018, International journal of cardiology.
[38] M. Taramasso,et al. Haemodynamic mechanisms and long‐term prognostic impact of pulmonary hypertension in patients with severe aortic stenosis undergoing valve replacement , 2018, European journal of heart failure.
[39] R. Carter,et al. A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction , 2018, Circulation.
[40] J. Wild,et al. Identifying At-Risk Patients with Combined Pre- and Postcapillary Pulmonary Hypertension Using Interventricular Septal Angle at Cardiac MRI , 2018, Radiology.
[41] E. V. van Beek,et al. Progression of Hypertrophy and Myocardial Fibrosis in Aortic Stenosis , 2018, Circulation. Cardiovascular imaging.
[42] F. Maisano,et al. Pulmonary Hypertension in Aortic and Mitral Valve Disease , 2018, Front. Cardiovasc. Med..
[43] A. Voors,et al. Right ventricular-vascular coupling in heart failure with preserved ejection fraction and pre- vs. post-capillary pulmonary hypertension , 2018, European heart journal cardiovascular Imaging.
[44] M. Gladwin,et al. Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction , 2018, JAMA cardiology.
[45] W. Edwards,et al. Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction , 2017, Circulation.
[46] L. Ling,et al. Right ventricular dysfunction in left‐sided heart failure with preserved versus reduced ejection fraction , 2017, European journal of heart failure.
[47] G. Weisz,et al. Pulmonary Hypertension with Left Heart Disease: Prevalence, Temporal Shifts in Etiologies and Outcome. , 2017, The American journal of medicine.
[48] Richard B. Thompson,et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI) , 2017, Journal of Cardiovascular Magnetic Resonance.
[49] R. Naeije,et al. The overloaded right heart and ventricular interdependence , 2017, Cardiovascular research.
[50] A. Masri,et al. Outcomes of persistent pulmonary hypertension following transcatheter aortic valve replacement , 2017, Heart.
[51] T. Welte,et al. More on idiopathic pulmonary arterial hypertension with a low diffusing capacity , 2017, European Respiratory Journal.
[52] M. Guazzi,et al. Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction , 2017, European journal of heart failure.
[53] M. Guazzi,et al. Pulmonary Hypertension in Heart Failure: Pathophysiology, Pathobiology, and Emerging Clinical Perspectives. , 2017, Journal of the American College of Cardiology.
[54] Patrizio Lancellotti,et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, European heart journal cardiovascular Imaging.
[55] S. Plein,et al. Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review , 2016, Journal of Cardiovascular Magnetic Resonance.
[56] G. Lip,et al. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[57] S. Rosenkranz,et al. Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum. , 2016, Journal of the American College of Cardiology.
[58] T. Mihaljevic,et al. Effect of Pulmonary Vascular Pressures on Long-Term Outcome in Patients With Primary Mitral Regurgitation. , 2016, Journal of the American College of Cardiology.
[59] R. Pai,et al. Survival in Patients with Degenerative Mitral Stenosis: Results from a Large Retrospective Cohort Study. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[60] M. Humbert,et al. A global view of pulmonary hypertension. , 2016, The Lancet. Respiratory medicine.
[61] R. Ristl,et al. The right heart in heart failure with preserved ejection fraction: insights from cardiac magnetic resonance imaging and invasive haemodynamics , 2016, European journal of heart failure.
[62] R. Wachter,et al. Left ventricular heart failure and pulmonary hypertension , 2015, European heart journal.
[63] D. Corrado,et al. Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death , 2015, Circulation.
[64] Victor Mor-Avi,et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.
[65] Shunichi Homma,et al. Prevalence and prognostic value of subclinical left ventricular systolic dysfunction by global longitudinal strain in a community‐based cohort , 2014, European journal of heart failure.
[66] J. Wild,et al. LGE patterns in pulmonary hypertension do not impact overall mortality. , 2014, JACC. Cardiovascular imaging.
[67] V. Nkomo,et al. Prognostic impact of pulmonary artery systolic pressure in patients undergoing transcatheter aortic valve replacement for aortic stenosis. , 2014, The American journal of cardiology.
[68] E. Nagel,et al. Cardiac magnetic resonance imaging findings and the risk of cardiovascular events in patients with recent myocardial infarction or suspected or known coronary artery disease: a systematic review of prognostic studies. , 2014, Journal of the American College of Cardiology.
[69] G. Nickenig,et al. Decrease of pulmonary hypertension impacts on prognosis after transcatheter aortic valve replacement. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[70] W. Kuebler,et al. Pulmonary veins in the normal lung and pulmonary hypertension due to left heart disease. , 2013, American journal of physiology. Lung cellular and molecular physiology.
[71] Tevfik F Ismail,et al. The Prevalence and Prognostic Significance of Right Ventricular Systolic Dysfunction in Nonischemic Dilated Cardiomyopathy , 2013, Circulation.
[72] S. Rosenkranz,et al. Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry. , 2013, International journal of cardiology.
[73] N. Westerhof,et al. Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses , 2013, European Respiratory Journal.
[74] J. Zamorano,et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. , 2013, European heart journal cardiovascular Imaging.
[75] M. Enriquez-Sarano,et al. Right Ventricular Systolic Function in Organic Mitral Regurgitation: Impact of Biventricular Impairment , 2013, Circulation.
[76] M. Cameli,et al. Right ventricular longitudinal strain and right ventricular stroke work index in patients with severe heart failure: left ventricular assist device suitability for transplant candidates. , 2012, Transplantation proceedings.
[77] Amit R. Patel,et al. Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension , 2012, Journal of Cardiovascular Magnetic Resonance.
[78] V. Roger,et al. Pulmonary pressures and death in heart failure: a community study. , 2012, Journal of the American College of Cardiology.
[79] James O. Mudd,et al. Pulmonary Capillary Wedge Pressure Augments Right Ventricular Pulsatile Loading , 2012, Circulation.
[80] B. Griffith,et al. Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: implications for timing of surgery. , 2011, The Journal of thoracic and cardiovascular surgery.
[81] Victor Mor-Avi,et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. , 2011, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[82] M. Enriquez-Sarano,et al. Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study. , 2011, European heart journal.
[83] V. Ferrari,et al. Shape of the right ventricular Doppler envelope predicts hemodynamics and right heart function in pulmonary hypertension. , 2011, American journal of respiratory and critical care medicine.
[84] R. Arena,et al. Pulmonary hypertension with left-sided heart disease , 2010, Nature Reviews Cardiology.
[85] C. Bauters,et al. Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation , 2010, Heart.
[86] L. Pierard,et al. Exercise Pulmonary Hypertension in Asymptomatic Degenerative Mitral Regurgitation , 2010, Circulation.
[87] G. Raskob,et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. , 2010, Chest.
[88] G. Filippatos,et al. Effects of Right Ventricular Ejection Fraction on Outcomes in Chronic Systolic Heart Failure , 2010, Circulation.
[89] P. Varadarajan,et al. Survival benefit of aortic valve replacement in patients with severe aortic regurgitation and pulmonary hypertension. , 2009, The Annals of thoracic surgery.
[90] A. Haque,et al. Pulmonary and cardiovascular complications of obesity: an autopsy study of 76 obese subjects. , 2008, Archives of pathology & laboratory medicine.
[91] R. Bansal,et al. Aortic valve replacement improves survival in severe aortic stenosis associated with severe pulmonary hypertension. , 2007, The Annals of thoracic surgery.
[92] R. Kwong,et al. Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction. , 2007, Journal of the American College of Cardiology.
[93] F. López-Ríos,et al. Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure , 2005, European journal of heart failure.
[94] R. Mohiaddin,et al. Applications of phase-contrast flow and velocity imaging in cardiovascular MRI , 2005, European Radiology.
[95] Warren J Manning,et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. , 2004, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[96] Robert R Edelman,et al. Contrast-enhanced MR imaging of the heart: overview of the literature. , 2004, Radiology.
[97] M. Enriquez-Sarano,et al. Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implications. , 2002, Journal of the American College of Cardiology.
[98] O. Simonetti,et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.
[99] J. Tomashefski,et al. Cardiopulmonary pathology in patients with sleep apnea/obesity hypoventilation syndrome. , 1997, Human pathology.
[100] J. West,et al. Vulnerability of pulmonary capillaries in heart disease. , 1995, Circulation.
[101] D. Moodie,et al. Primary pulmonary hypertension, then and now: 28 years of experience. , 1992, Cleveland Clinic journal of medicine.
[102] C. Wagenvoort. Morphological substrate for the reversibility and irreversibility of pulmonary hypertension. , 1988, European heart journal.
[103] C. Wagenvoort. Lung biopsy specimens in the evaluation of pulmonary vascular disease. , 1980, Chest.
[104] H. Tandon,et al. Pulmonary vascular changes associated with isolated mitral stenosis in India. , 1975, British heart journal.
[105] E. W. Hancock,et al. Regression of extreme pulmonary hypertension after mitral valve surgery. , 1972, The American journal of cardiology.
[106] W. Evans,et al. PULMONARY HYPERTENSION IN MITRAL STENOSIS , 1957, British heart journal.
[107] G. Myers,et al. Correlation of pulmonary arteriolar resistance with pulmonary vascular changes in patients with mitral stenosis before and after valvulotomy. , 1955, The New England journal of medicine.
[108] A. Rigby,et al. Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials , 2018, European heart journal.
[109] J. Zamorano,et al. Four chamber right ventricular longitudinal strain versus right free wall longitudinal strain. Prognostic value in patients with left heart disease. , 2016, Cardiology journal.
[110] P. Sengupta,et al. Pulmonary hypertension in valvular disease: a comprehensive review on pathophysiology to therapy from the HAVEC Group. , 2015, JACC. Cardiovascular imaging.
[111] G. Pedrizzetti,et al. Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. , 2015, European heart journal cardiovascular Imaging.